EX-99.1 2 v386372_ex99-1.htm EXHIBIT 99.1

 

Sapiens Logo notag.jpg

 

Sapiens Reports Record Quarterly Revenue of $38.6 Million,
Up 16.9% Year-Over-Year

 

Non-GAAP Operating Profit increased by 19.6%

 

Holon, Israel, August 12, 2014 Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announced today its financial results for the second quarter ended June 30, 2014.

 

Second Quarter Highlights:

 

·Non- GAAP Revenue increased by 16.9% to $38.6 million from the second quarter of 2013

 

·Non- GAAP operating profit was $4.0 million compared to $3.3 million in the second quarter of 2013, an increase of 19.6%.

 

·Non-GAAP net income attributable to Sapiens' shareholders increased by 13.0% to $3.6 million, or $0.07 cents per diluted share compared to $3.2 million.

 

·Cash, cash equivalents and securities investments as of June 30, 2014 was $79.8 million, with no debt.

 

·Launch of Sapiens Retirement Services Platform, the next generation of technology for the defined contribution retirement services industry.

 

·Released Sapiens IDIT core version (11.2) which increases the number of out of the box standard web-services and provides new framework for country level interfaces.

 

·Acquired KPI, owner of “The Decision Model” patent and a leading decision management consultancy firm.

 

First half Highlights:

 

·Non-GAAP revenue increased by 16.6% to $75.3 million from the same period of 2013.

 

·Non-GAAP operating profit was $7.7 million compared to $6.7 million in the first six months of 2013, an increase of 14.2%.

 

·Non-GAAP net income attributable to Sapiens' shareholders reached $7.0 million, compared to $6.6 million in the year ago period, an increase of 6.0%.

 

 

1
 

 

Roni Al-Dor, President and CEO of Sapiens, commented: "This was another strong quarter in which we delivered double-digit revenue and operating profit growth. We continued to make strategic investments in sales, marketing and product development, without compromising current period profits or margins. Our market presence was expanded as we booked growth from both new and existing clients and qualified new opportunities to expand our pipeline across all geographies and products. Clearly, we are executing and delivering on our near-term commitments for growth while balancing profitability and investments for the longer-term potential of the company.”

 

Mr. Al-Dor concluded, “Our business plan remains solid and we are confident in our ability to deliver full-year 2014 revenue in line with our guidance of $154 million to $158 million."

 

 

Quarterly Results Conference Call

 

Sapiens management will host its earnings conference call today, August 12th, 2014 at 9:30 am EDT, 4:30 pm Israel, to discuss the results. To participate in the call, please dial in to the following numbers: United States + 1.888.668.9141; International: +972.3. 918.0610; UK: 0.800.917.5108.
The call will be webcast live on the Company’s website at http://www.sapiens.com/webcasts-presentations.htm.
An online replay will also be available approximately two hours following the call. A telephone replay of the call will be available for 7 days after the live broadcast, and may be accessed by dialing: North America: +1.888.254.7270; International: +972.3.925.5904.

 

 

Non-GAAP Financial Measures

 

This press release contains the following non-GAAP financial measures: Non-GAAP revenue, Non-GAAP gross profit, Non-GAAP operating income, Non-GAAP net income attributed to Sapiens shareholders, Non-GAAP basic and diluted earnings per share.

 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

 

2
 

 

Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

 

The Company defines Adjusted EBITDA as net Profit, adjusted for stock-based compensation expense, depreciation and amortization, capitalized internal-use software development costs, Amortization of internal-use software development costs interest expense, provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business. The Company uses Adjusted EBITDA as a measurement of its operating performance because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflect an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures provide a more complete understanding of factors and trends affecting its business.

 

3
 

 

About Sapiens

 

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, and retirement markets, as well as business decision management software. We have a track record of over 30 years in delivering superior software solutions to more than 130 financial services organizations. Our team of more than 900 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.

 

 

Forward Looking Statement

 

Some of the statements in this press release may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management’s current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement. These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties as well as certain additional risks that we face, you should refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2013 and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

 

 

Investors and Media Contact:

 


Yaffa Cohen-Ifrah

 

Vice President Corporate Marketing and Communications

Sapiens International

Phone: +972-3-790 2026

Email: yaffa.cohen-ifrah@sapiens.com

 

4
 

 

Summary of Non-GAAP financial Information
U.S. dollars in thousands (except per share amounts)

   Three months ended   Six months ended 
   June 30,   June 30, 
   2014   2013   2014   2013 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
 Revenues   38,651    33,065    75,279    64,572 
 Gross profit   15,675    13,583    30,323    27,068 
 Operating profit   4,001    3,344    7,653    6,699 
 Net income attributable to Sapiens' shareholders   3,601    3,188    6,976    6,580 
Adjusted EBITDA   4,417    3,616    8,437    7,233 
 Basic earnings per share   0.08    0.08    0.15    0.17 
 Diluted earnings per share   0.07    0.08    0.14    0.16 
                     

 

Revenues by category
U.S. dollars in thousands

   Three months ended June 30, 2014   Six months ended June 30, 2014 
   Revenues   Percentage   Revenues   Percentage 
     
License   3,990    10.3%   7,890    10.5%
Services and Maintenance   34,661    89.7%   67,389    89.5%
Total   38,651    100.0%   75,279    100.0%

 

5
 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

   Three months ended   Six months ended 
   June 30,   June 30, 
   2014   2013   2014   2013 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
 Revenue   38,651    33,065    75,279    64,572 
 Cost of revenue   24,653    20,840    47,904    40,203 
                     
 Gross profit   13,998    12,225    27,375    24,369 
                     
 Operating Expenses:                    
 Research and development, net   2,855    2,954    5,744    6,178 
 Selling, marketing, general and administrative   7,760    6,409    15,074    12,749 
 Total operating expenses   10,615    9,363    20,818    18,927 
                     
 Operating income   3,383    2,862    6,557    5,442 
                     
 Financial income, net   (11)   (21)   (57)   (306)
 Taxes and other expenses, net   283    152    462    427 
                     
                     
 Net income   3,111    2,731    6,152    5,321 
                     
 Attributable to non-controlling interest   6    54    25    11 
                     
 Net income attributable to Sapiens' shareholders   3,105    2,677    6,127    5,310 
                     
                     
 Basic earnings per share   0.07    0.07    0.13    0.14 
                     
 Diluted earnings per share   0.06    0.06    0.13    0.13 
                     
 Weighted average number of shares                    
 outstanding used to compute:                    
                     
 Basic earnings per share   47,177    39,120    46,797    38,945 
 Diluted earnings per share   48,759    41,399    48,362    41,107 

 

6
 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

   Three months ended   Six months ended 
   June 30,   June 30, 
   2014   2013   2014   2013 
 Non-GAAP revenue   38,651    33,065    75,279    64,572 
                     
                     
 GAAP gross profit   13,998    12,225    27,375    24,369 
 Amortization of capitalized software   1,459    1,138    2,506    2,262 
 Amortization of other intangible assets   218    220    442    437 
 Non-GAAP gross profit   15,675    13,583    30,323    27,068 
                     
                     
 GAAP operating income   3,383    2,862    6,557    5,442 
 Gross profit adjustments   1,677    1,358    2,948    2,699 
 Capitalization of software development   (1,686)   (1,430)   (3,087)   (2,538)
 Amortization of other intangible assets   339    314    676    642 
 Stock-based compensation   288    240    559    454 
 Non-GAAP operating income   4,001    3,344    7,653    6,699 
                     
                     
 GAAP net income attributable to Sapiens' shareholders   3,105    2,677    6,127    5,310 
 Operating income adjustments   618    482    1,096    1,257 
 Other   (122)   29    (247)   13 
 Non-GAAP net income attributable to Sapiens' shareholders   3,601    3,188    6,976    6,580 
                     
                     
                     
 Non-GAAP basic earnings per share   0.08    0.08    0.15    0.17 
                     
 Non-GAAP diluted earnings per share   0.07    0.08    0.14    0.16 
                     
                     
Shares used in computing US NON GAAP basic earnings
per share (in thousands)
   47,177    39,120    46,797    38,945 
Shares used in computing US NON GAAP diluted earnings
per share (in thousands)
   48,759    41,399    48,362    41,107 
                     

 

7
 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. Dollars in thousands

   June 30,   December 31, 
   2014   2013 
   (unaudited)   (unaudited) 
         
ASSETS        
         
CURRENT ASSETS:        
Cash and cash equivalents   45,374    70,313 
Trade receivables, net   25,644    23,669 
 Other receivables and prepaid expenses   3,512    4,126 
 Deferred Taxes   1,862    2,420 
           
 Total current assets   76,392    100,528 
           
 LONG-TERM ASSETS:          
Marketable Securities   34,377    - 
Property and equipment, net   5,664    5,263 
Severance pay fund   12,131    11,228 
Other intangible assets, net   29,751    30,014 
Other long-term assets   3,093    2,957 
Goodwill   72,922    72,438 
           
 Total long-term assets   157,938    121,900 
           
 TOTAL ASSETS   234,330    222,428 
           
 LIABILITIES AND EQUITY          
           
 CURRENT LIABILITIES:          
 Trade payables   4,592    6,517 
 Accrued expenses and other liabilities   24,585    21,248 
Deferred revenue   11,024    9,928 
           
 Total current liabilities   40,201    37,693 
           
 LONG-TERM LIABILITIES:          
 Other long-term liabilities   1,269    1,712 
 Accrued severance pay   13,686    12,615 
           
 Total long-term liabilities   14,955    14,327 
           
 EQUITY   179,174    170,408 
           
 TOTAL LIABILITIES AND EQUITY   234,330    222,428 

 

8
 

 

SAPIENS INTERNATIONAL CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. Dollars in thousands

   For the six months ended 
   30/06/2014   30/06/2013 
   (unaudited)   (unaudited) 
Cash flows from operating activities:          
Net profit   6,152    5,321 
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation and amortization   4,408    3,875 
Amortization of premium and accrued interest on marketable securities   23    - 
Stock-based compensation related to options issued employees   559    454 
Increase in trade receivables   (1,790)   (4,599)
Deferred tax assets   85    (956)
Decrease (Increase) in other operating assets   299    (459)
Increase (Decrease)  in trade payables   (1,994)   3,304 
Increase (Decrease) in Other operating liabilities   3,053    (1,187)
Increase  in Deferred revenues   1,001    3,164 
Severance pay   152    181 
           
Net cash provided by operating activities   11,948    9,098 
           
Cash flows from investing activities:          
Purchase of property and equipment   (1,224)   (1,674)
Purchase of marketable securities   (34,786)   - 
Increase in capitalized software development costs   (3,087)   (2,540)
Decrease in Restricted Cash   541    191 
Net cash used in investing activities   (38,556)   (4,023)
           
Cash flows from financing activities:          
Distribution of dividend   -    (5,803)
Proceeds from employee stock options exercised   1,305    1,333 
Net cash provided by (used in) financing activities   1,305    (4,470)
           
Effect of exchange rate changes on cash and cash equivalents   364    (503)
           
Increase (decrease) in cash and cash equivalents   (24,939)   102 
Cash and cash equivalents at the beginning of period   70,313    29,050 
           
Cash and cash equivalents at the end of period   45,374    29,152 

 

9